DRG uses cookies to improve your experience on this website. Some of the cookies we use are essential for parts of the website to operate. Please be aware that if you continue without changing your cookie settings, you consent to this. For more information on our use of cookies, please review our cookie policy.

Biosimilars Insights Infographic

Global Biosimilars Pathways and Clinical Development Activity

Since the introduction of the first biosimilar guidelines in 2005, the biosimilars field has continued to evolve. 25 biosimilars are currently marketed in the United States and Europe alone. While Europe has long led the way in terms of biosimilars guidelines and clinical development, other countries/regions are catching up, fast. Clinical development of biosimilars is taking place across the globe, increasingly in emerging markets. Download our infographic to find out more about where the biosimilars hotspots are.